- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03935620
Delivering Early Intervention to Children With Down Syndrome
February 27, 2022 updated by: Emily Quinn, Oregon Health and Science University
Delivering Early Intervention to Children With Down Syndrome Through Telemedicine
Children with Down syndrome (DS) are at risk for significant language and communication impairments.
Enhancing the service delivery of early intervention for children with DS is a key research and policy issue given the prevalence and detrimental effects of persistent language impairments.
Using a telemedicine approach allows clinicians to provide evidence-based treatment to families from a wide geographic area in Oregon who may not otherwise have access to a language intervention specialized for children with DS.
Our innovative project involves the creation of a new treatment optimized for children with DS, as it will be the first study that translates an existing evidence-based language intervention-Enhanced Milieu Teaching (EMT) into a telemedicine model.
The goal of this study is to examine whether a telemedicine approach is effective for training parents to implement EMT language support strategies and whether changes in parent behavior are associated with child communication and language growth.
The investigators will pilot the telemedicine initiative to provide early intervention services to ten children with DS (aged 18- 48 months) and their families who live in rural and /or under-served areas of Oregon.
The investigators will use single-case research design methodology to pilot this intervention research.
The investigators will use secure video-teleconferencing technology to provide EMT.
Clinicians will provide EMT to parents through interactive coaching, teaching them how to foster their children's social communication and language skills.
Outcomes will focus on parents' use of language support strategies and children's social communication and language skills.
Delivering early intervention to children with DS and providing parent-training at a distance using a telemedicine approach has the potential to transform the delivery of early language interventions for children with DS. Results of this study will directly inform the development and refinement of language interventions for young children with DS.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
- Aim 1: To examine the effect of using a telemedicine service delivery model to teach parents of children with DS to use EMT language support strategies. The investigators hypothesize that parents will learn to use EMT language support strategies from the personalized instruction provided during 36 intervention sessions.
- Aim 2: To examine the effect of delivering EMT using a telemedicine service delivery model to improve the spoken language and social communication skills of children with DS. The investigators hypothesize that improvements in child communication and language skills will result from increasing parents' use of EMT language support strategies during everyday parent-child interactions such as play with toys, singing songs, book reading, and mealtimes.
Study Type
Interventional
Enrollment (Actual)
3
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97236
- Oregon Health and Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 3 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- child age between 18 and 36 months
- developmental age of 9 months as measured on the Visual Reception Scale of the Mullen Scales of Early Learning (MSEL; Mullen, 1995)
- primary diagnosis of Down syndrome as indicated in medical history,
- secondary diagnosis of language delay as measured by a score of at least 1.33 SD below the mean on the Preschool Language Scales -5th Edition (PLS-5; Zimmerman, Steiner, & Evatt-Pond, 2011),
- hearing (with or without amplification) reported at 25dB HL or better confirmed by audiological testing, or medical record.
Exclusion Criteria:
- concomitant sensory impairments (e.g., hearing impairment, blindness), and
- symptoms of autism spectrum disorder as measured by a result indicating "high risk" for autism (e.g., scores of 8 or higher) on the Modified Checklist for Autism In Toddlers-Revised with Follow-up (MCHAT-R/F Robins, Fein & Barton, 2009).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: EMT
After a period of stable baseline performance (3 to 5 sessions) for parents and children the interventionists will apply the EMT Language Intervention.
|
Enhanced Milieu Teaching (EMT) an evidence-based, naturalistic language intervention that has been optimized to address the specific language and communication deficits associated with DS.
EMT is a parent-implemented intervention that involves home-visits during which clinicians teach parents to support their child learning language during typical parent-child interactions at home (play with toys, music, book reading, and snack time).
Clinicians follow an evidence-based instructional framework called "Teach-Model-Coach-Review" to teach parents language support strategies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Between Session Change:Number of EMT Strategies Used by Parents During Parent-Child Interaction
Time Frame: Assessed 1-2 times per week for 3- 4 months.
|
Observational measure coded from video-recordings of a 15 minute caregiver-child interaction.
10 minutes of play and toys and 5 minutes of a home routine.
Changes in the number of different EMT strategies used by parents will be quantified.
|
Assessed 1-2 times per week for 3- 4 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Between Session Change: Rate of Symbolic Communication During Parent-Child Interaction
Time Frame: Assessed 1-2 times per week for 3-4 months.
|
Observational measure coded from video-recordings of a 15 minute caregiver-child interaction.
10 minutes of play and toys and 5 minutes of a home routine.
|
Assessed 1-2 times per week for 3-4 months.
|
|
Communication Matrix Scores
Time Frame: Assessed at T00 (Study Entry) and T01 (3- 4 months post intervention).
|
Total score on an assessment of early expressive communication skills.
|
Assessed at T00 (Study Entry) and T01 (3- 4 months post intervention).
|
|
Between Session Change: Number of Different Words Expressed During Parent-Child Interaction
Time Frame: Assessed 1-2 times per week for 3-4 months.
|
Observational measure coded from video-recordings of a 15 minute caregiver-child interaction.
10 minutes of play and toys and 5 minutes of a home routine.
|
Assessed 1-2 times per week for 3-4 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2019
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
December 1, 2021
Study Registration Dates
First Submitted
April 29, 2019
First Submitted That Met QC Criteria
April 30, 2019
First Posted (Actual)
May 2, 2019
Study Record Updates
Last Update Posted (Actual)
March 2, 2022
Last Update Submitted That Met QC Criteria
February 27, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00018508
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Down Syndrome
-
Rachel G. Greenberg, MD, MB, MHSEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedHyperactivity in Children With Down Syndrome | Impulsivity in Children With Down SyndromeUnited States
-
Izgi Miray DemirbagRecruitingDown Syndrome (DS)Turkey (Türkiye)
-
Brigham and Women's HospitalNational Institutes of Health (NIH)Not yet recruitingDown Syndrome (DS)United States
-
University of Nevada, Las VegasRecruiting
-
Universidad de BurgosEuropean University Miguel de CervantesRecruiting
-
Aelis FarmaHospital del Mar Research Institute (IMIM)Enrolling by invitation
-
Sohag UniversityActive, not recruitingDown Syndrome | Cervical Spine Instability in Down SyndromeEgypt
-
Riphah International UniversityCompletedDown S SyndromePakistan
-
Hoffmann-La RocheCompletedHealthy Volunteer, Down SyndromeUnited Kingdom
-
Cairo UniversityCompleted
Clinical Trials on Enhanced Milieu teaching
-
Father Flanagan's Boys' HomeVanderbilt University Medical Center; National Institute on Deafness and Other...WithdrawnAutism Spectrum Disorder | Autism SiblingUnited States
-
Vanderbilt UniversityCompletedLanguage Developmental DisordersUnited States
-
Oregon Health and Science UniversityAgency for Healthcare Research and Quality (AHRQ)Withdrawn
-
University of Wisconsin, MadisonNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism Spectrum Disorder | Language Development DisordersUnited States
-
Father Flanagan's Boys' HomeNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingAutism Spectrum Disorder | Autism | Autism, Susceptibility to, 6United States
-
Northwestern UniversityVanderbilt University; University of Illinois at Urbana-ChampaignCompletedDevelopmental Language DisorderUnited States
-
University of KansasNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedDevelopmental Disabilities | Communication DisordersUnited States
-
Kaohsiung Medical University Chung-Ho Memorial...Completed
-
Beth Israel Deaconess Medical CenterTerminatedBreast NeoplasmsUnited States
-
Pontificia Universidade Católica do Rio Grande...Unknown